Long-term aspirin use linked to reduced risk of colorectal cancer -- NEJM study.
This article was originally published in The Tan Sheet
Executive Summary
ASPIRIN FOUND TO "SUBSTANTIALLY REDUCE" COLORECTAL CANCER RISK in a group of women taking the drug regularly for decades, according to an article based on data from the Nurses' Health Study that appears in the Sept. 7 issue of the New England Journal of Medicine. Edward Giovannucci, MD et al., Harvard Medical School, noted, however, that "this benefit may not be evident until after at least a decade of regular aspirin consumption."